Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(02): 16-18
DOI: 10.1055/s-0041-1733069
Original Article

Experience with Venous Access Devices in Pediatric Cancer Patients

Tulika Seth
Department of Medical Oncology, Institute Rotary Cancer Hospital, AIIMS, New Delhi 110029, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
28 March 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 O’Grady NP, Alexander M, Dellinger EP,et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for disease control and prevention. MMWR Recomm Rep. 2002; 51(RR-10):1-29.
  • 2 Carlisle PS, Gucalp R, Wiernik PH. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993;14:320-324.
  • 3 Morrison VA, Peterson BA, Bloomfield CD. Nosocomial septicemia in the cancer patients: the influence of central venous access devices, neutropenia and type of malignancy. Med Ped Oncol 1990;18:209-216.
  • 4 Mueller BU, Skelton J, P.E.Callender D, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. Jn Clinical Oncology; 10: 1992: 1943- 48.
  • 5 Simon A, Fleischhack G, Hasan C, et al. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infections Control and Hospital Epidemiology, 2000;21 592-596.
  • 6 Nowak-Gottl U, Ahlke E, Gleischhack G, et al. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols):prednisone versus dexamethasone administration. Blood, 2003; 101,2529-33.
  • 7 Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998;19:842-5
  • 8 Raad H, Hohn DC, Gilbreath BJ. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-8
  • 9 Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-43.
  • 10 Richet H, Hubert B, Nitemberg G. Prospective multicenter study of vascular-catheter related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990;28:2520-5.
  • 11 .Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257-66.